1. Home
  2. ACFN vs VNRX Comparison

ACFN vs VNRX Comparison

Compare ACFN & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACFN

Acorn Energy Inc.

N/A

Current Price

$15.79

Market Cap

35.2M

ML Signal

N/A

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.27

Market Cap

38.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACFN
VNRX
Founded
1986
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.2M
38.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACFN
VNRX
Price
$15.79
$0.27
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$3.17
AVG Volume (30 Days)
23.8K
2.8M
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
473.47
N/A
EPS
2.64
N/A
Revenue
$12,630,000.00
$1,472,007.00
Revenue This Year
N/A
$55.33
Revenue Next Year
N/A
$493.79
P/E Ratio
$6.27
N/A
Revenue Growth
30.11
14.48
52 Week Low
$12.42
$0.27
52 Week High
$33.00
$0.94

Technical Indicators

Market Signals
Indicator
ACFN
VNRX
Relative Strength Index (RSI) 45.44 31.94
Support Level $15.63 $0.28
Resistance Level $17.53 $0.31
Average True Range (ATR) 1.15 0.03
MACD 0.59 0.00
Stochastic Oscillator 65.94 3.40

Price Performance

Historical Comparison
ACFN
VNRX

About ACFN Acorn Energy Inc.

Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: